
A €15 million global clinical trial has been initiated to evaluate the efficacy of phage therapy as a treatment for urinary tract infections.
The study aims to address rising antibiotic resistance by utilizing bacteriophages to target specific bacterial pathogens responsible for chronic infections.
This research is part of a broader effort to advance alternative antimicrobial treatments in the face of declining traditional antibiotic effectiveness.